Teladoc Stock Analysis


USD 25.90  0.14  0.54%   

The current Teladoc price slip created some momentum for investors as it was traded today as low as 25.52 and as high as 26.56 per share. The company directors and management were unable to exploit market volatilities in November. However, diversifying your overall positions with Teladoc can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.27. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Teladoc partners.
Additionally, take a look at World Market Map.
The Teladoc stock analysis report makes it easy to digest most publicly released information about Teladoc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Teladoc Stock analysis module also helps to analyze the Teladoc price relationship with some important fundamental indicators such as market cap and management efficiency.

Teladoc Stock Analysis Notes

About 84.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.78. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teladoc recorded a loss per share of 43.42. The entity had not issued any dividends in recent years. Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company was incorporated in 2002 and is headquartered in Purchase, New York. Teladoc Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 4335 people. To find out more about Teladoc contact Jason Gorevic at 203 635 2002 or learn more at

Teladoc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Teladoc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Teladoc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Teladoc generated a negative expected return over the last 90 days
Teladoc has high historical volatility and very poor performance
The company reported the previous year's revenue of 2.03 B. Net Loss for the year was (428.79 M) with profit before overhead, payroll, taxes, and interest of 1.38 B.
Over 84.0% of the company shares are owned by institutional investors
Latest headline from Retirement Stock Portfolio 11 Safe Healthcare Stocks to Consider - Yahoo Finance

Teladoc Upcoming and Recent Events

Earnings reports are used by Teladoc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Teladoc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report23rd of February 2022
Next Financial Report27th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End23rd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Teladoc Thematic Classifications

In addition to having Teladoc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Corona Opportunity
Coronavirus related entities to consider during and after the outbreak

Teladoc Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teladoc's market, we take the total number of its shares issued and multiply it by Teladoc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Teladoc Profitablity

Teladoc's profitability indicators refer to fundamental financial ratios that showcase Teladoc's ability to generate income relative to its revenue or operating costs. If, let's say, Teladoc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Teladoc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Teladoc's profitability requires more research than a typical breakdown of Teladoc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Investment(1.54) (1.66) 
Return on Average Assets(2.42) (2.61) 
Return on Average Equity(2.69) (2.90) 
Return on Invested Capital(0.74) (0.79) 
Return on Sales(0.67) (0.73) 

Management Efficiency

The entity has return on total asset (ROA) of (0.0113) % which means that it has lost $0.0113 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.8948) %, meaning that it created substantial loss on money invested by shareholders. Teladoc management efficiency ratios could be used to measure how well teladoc manages its routine affairs as well as how well it operates its assets and liabilities. As of December 7, 2022, Return on Investment is expected to decline to -1.66. In addition to that, Return on Average Assets is expected to decline to -2.61. Teladoc Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 17.73 Billion. The current year Current Assets is expected to grow to about 1.3 B, whereas Assets Non Current are forecasted to decline to about 56.1 M.
Last ReportedProjected for 2022
Book Value per Share 8.07  8.71 
Enterprise Value over EBIT(9.90) (10.68) 
Enterprise Value over EBITDA(11.73) (12.66) 
Price to Book Value 3.48  3.46 
Tangible Assets Book Value per Share 7.15  9.71 
Enterprise Value597.3 M593.8 M
Tangible Asset Value142.3 M153.6 M

Technical Drivers

As of the 7th of December, Teladoc has the risk adjusted performance of (0.021976), and Coefficient Of Variation of (5,248). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teladoc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Teladoc, which can be compared to its competition. Please validate Teladoc treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Teladoc is priced more or less accurately, providing market reflects its prevalent price of 25.9 per share. Given that Teladoc has jensen alpha of (0.25), we advise you to double-check Teladoc's current market performance to make sure the company can sustain itself at a future point.

Teladoc Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Teladoc middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Teladoc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Teladoc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teladoc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teladoc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Teladoc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Richard Napolitano over two months ago via Macroaxis 
Exercise or conversion by Richard Napolitano of 601 shares of Teladoc Health subject to Rule 16b-3
Daniel Trencher over two months ago via Macroaxis 
Sale by Daniel Trencher of 1000 shares of Teladoc Health
Arnnon Geshuri over three months ago via Macroaxis 
Sale by Arnnon Geshuri of 4098 shares of Teladoc Health
Daniel Trencher over three months ago via Macroaxis 
Sale by Daniel Trencher of 1000 shares of Teladoc Health
Waters Michael Willem over three months ago via Macroaxis 
Acquisition by Waters Michael Willem of 135833 shares of Teladoc Health subject to Rule 16b-3
Mala Murthy over three months ago via Macroaxis 
Exercise or conversion by Mala Murthy of 7968 shares of Teladoc Health subject to Rule 16b-3
Daniel Trencher over three months ago via Macroaxis 
Sale by Daniel Trencher of 1000 shares of Teladoc Health
Jensen Claus Torp over six months ago via Macroaxis 
Acquisition by Jensen Claus Torp of 24525 shares of Teladoc Health subject to Rule 16b-3
Arnnon Geshuri over six months ago via Macroaxis 
Sale by Arnnon Geshuri of 2888 shares of Teladoc Health
Karen Daniel over six months ago via Macroaxis 
Sale by Karen Daniel of 410 shares of Teladoc Health
Catherine Jacobson over six months ago via Macroaxis 
Exercise or conversion by Catherine Jacobson of 1638 shares of Teladoc Health subject to Rule 16b-3
David Snow over six months ago via Macroaxis 
Exercise or conversion by David Snow of 1638 shares of Teladoc Health subject to Rule 16b-3

Teladoc Technical and Predictive Indicators

Teladoc Forecast Models

Teladoc time-series forecasting models is one of many Teladoc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teladoc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Teladoc Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Teladoc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teladoc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Teladoc. By using and applying Teladoc Stock analysis, traders can create a robust methodology for identifying Teladoc entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(13.07) (14.10) 
EBITDA Margin(14.53) (15.68) 
Gross Margin 68.01  77.27 
Profit Margin(21.09) (22.76) 

Current Teladoc Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teladoc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Teladoc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Teladoc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Teladoc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Teladoc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Teladoc, talking to its executives and customers, or listening to Teladoc conference calls.
Teladoc Analyst Advice Details

Teladoc Stock Analysis Indicators

Teladoc stock analysis indicators help investors evaluate how Teladoc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Teladoc shares will generate the highest return on investment. By understating and applying Teladoc stock analysis, traders can identify Teladoc position entry and exit signals to maximize returns.
Begin Period Cash Flow733324000.00
Logo U R LimglogosUSTDOC.png
Common Stock Shares Outstanding90509229.00
Total Stockholder Equity16045757000.00
DescriptionTeladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical
Total Cashflows From Investing Activities-72981000.00
Tax Provision44137000.00
Property Plant And Equipment Net74014000.00
Retained Earnings-1421454000.00
Cash And Short Term Investments896017000.00
Retained Earnings Total Equity-1421454000.00
Accounts Payable47257000.00
Net Debt386651000.00
50 Day M A27.3518
Total Current Liabilities331013000.00
Currency CodeUSD
Other Operating Expenses2271695000.00
Non Current Assets Total16509169000.00
Forward Price Earnings357.1429
Common Stock Total Equity160000.00
Non Currrent Assets Other20703000.00
Additionally, take a look at World Market Map. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for analysis

When running Teladoc price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Teladoc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine Teladoc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.